Literature DB >> 10420179

Human corneal epithelial cell adhesion to laminins.

M A Kurpakus1, C Daneshvar, J Davenport, A Kim.   

Abstract

PURPOSE: To analyze alpha-integrin mediated adhesion of human corneal epithelial cells to placental and EHS laminin isoforms.
METHODS: Western blot analysis was used to partially characterize commercially available preparations of laminin isolated from the mouse EHS sarcoma and from human placenta. Using the human corneal epithelial cell line HCE-T, adhesion to laminin isoforms and fibronectin was determined using a colorimetric adhesion assay. alpha-integrin sub-unit modulation of corneal epithelial cell interaction with laminin isoforms was analyzed using immunofluorescence microscopy and adhesion assays incorporating functional blocking antibodies.
RESULTS: In short-term adhesion assays, the preferred substrate for HCE-T attachment is placental laminin. Immunofluorescence microscopy reveals that alpha-integrin protein localization patterns are not significantly different in HCE-T interacting with EHS or placental laminin. However, in short-term assays alpha3 integrin plays a major role, and alpha2 integrin a minor role, in mediating HCE-T adhesion to laminin. alpha6 integrin does not appear to mediate adhesion to either substrate.
CONCLUSIONS: These studies demonstrate that human corneal epithelial cells are capable of rapid adhesion to, and enhanced spreading on, laminin isoforms not characteristically resident in the adult corneal basement membrane. This characteristic of human corneal epithelium may explain, at least in part, why amniotic membrane transplantation is proving to be clinically useful for human ocular surface reconstruction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10420179     DOI: 10.1076/ceyr.19.2.106.5330

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  8 in total

1.  Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway.

Authors:  Gabriel Sosne; Ping Qiu; Patricia L Christopherson; Michelle Kurpakus Wheater
Journal:  Exp Eye Res       Date:  2007-01-23       Impact factor: 3.467

2.  HCE-T cell line lacks cornea-specific differentiation markers compared to primary limbal epithelial cells and differentiated corneal epithelium.

Authors:  Anna-Klara Rubelowski; Lorenz Latta; Priya Katiyar; Tanja Stachon; Barbara Käsmann-Kellner; Berthold Seitz; Nóra Szentmáry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-11       Impact factor: 3.117

3.  Corneal epithelial cell biocompatibility to silicone hydrogel and conventional hydrogel contact lens packaging solutions.

Authors:  M B Gorbet; N C Tanti; L Jones; H Sheardown
Journal:  Mol Vis       Date:  2010-02-19       Impact factor: 2.367

4.  Laminin-2 stimulates the proliferation of epithelial cells in a conjunctival epithelial cell line.

Authors:  J Dowgiert; G Sosne; M Kurpakus-Wheater
Journal:  Cell Prolif       Date:  2004-04       Impact factor: 6.831

5.  Fabrication, Rheological, and Compositional Characterization of Thermoresponsive Hydrogel from Cornea.

Authors:  Ghasem Yazdanpanah; Yizhou Jiang; Behnam Rabiee; Meisam Omidi; Mark I Rosenblatt; Tolou Shokuhfar; Yayue Pan; Alexandra Naba; Ali R Djalilian
Journal:  Tissue Eng Part C Methods       Date:  2021-05       Impact factor: 3.056

6.  Limbal stem cells in review.

Authors:  Marzieh Ebrahimi; Ehsan Taghi-Abadi; Hossein Baharvand
Journal:  J Ophthalmic Vis Res       Date:  2009-01

7.  Proteome Composition of Bovine Amniotic Membrane and Its Potential Role in Corneal Healing.

Authors:  Erotides Capistrano da Silva; Justine Arrington; Peter M Yau; Kathryn M Smith-Fleming; Igor Frederico Canisso; Bianca da Costa Martins
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-02-01       Impact factor: 4.799

8.  The use of biological membranes for correction of congenital malformations.

Authors:  C Marchetto; A Sgrò; P Gamba; D Trojan; C Pagliara; P Midrio
Journal:  Cell Tissue Bank       Date:  2022-04-06       Impact factor: 1.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.